Healthy volunteers help test new liver Drug's safety
NCT ID NCT07110441
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 25 times
Summary
This early-stage study tested a new drug called G1090N in 52 healthy adults to measure how the body processes it and to check for side effects. The goal was not to treat any disease, but to gather important safety and dosing information before testing it in patients with liver problems. Participants took single or multiple doses of the drug and provided blood and urine samples.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE-ON-CHRONIC LIVER FAILURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Anaheim Clinical Trials, LLC
Anaheim, California, 92801, United States
Conditions
Explore the condition pages connected to this study.